Board of Directors

2023-2024 Board of Directors

Cheryl Anderson, BSPharm, R.Ph.
President
Kayce Shealy, Pharm.D., BCPS, CDCES
President-Elect
William Wynn, Pharm.D., R.Ph., BCMAS
Treasurer
Jennifer Baker, Pharm.D.
Immediate Past President
Alyssa Norwood, BSPharm, Pharm.D., R.Ph., BCGP, MS
Speaker, House of Delegates
Anthony DeClue, Pharm.D., MA, BCACP
Speaker-Elect, House of Delegates
Whitney Pence, Pharm.D.
At-Large Director
Emily Russell, Pharm.D.
Midlands Region Director
Erin Stelling, Pharm.D., MBA
Pee Dee Region Director
Deborah Bowers, Pharm.D., R.Ph., AFMC
Upstate Region Director
Donna Avant, R.Ph., CDCES
Lowcountry Region Director
Brian Clark, BSPharm, R.Ph.
CEO

Board of Directors Mission

On behalf of the membership, the Board of Directors assumes direct responsibility for defining and ensuring appropriate organizational performance.

  • More Details
    1. The Board will be the conduit linking the membership’s interests to operational performance.
    2. Needs Assessment: The Board will assess the needs of the membership as they relate to the Association’s activities and scope of influence, and will develop Ends policies identifying and prioritizing intended organizational outcomes to address those needs.  The House of Delegates will be a primary component of this “linkage.”
    3. Advocacy: The Board will inform the membership of the Association’s accomplishments on its behalf, and of expected future results.
      1. The Board will develop and maintain written governing policies that realistically address the broadest levels of all organizational decisions and situations:
      2. ENDS: Organizational products, effects, benefits, outcomes, recipients, and their relative worth (what good for which recipients at what relative worth/cost/priority).
      3. MANAGEMENT LIMITATIONS: Constraints on executive authority that establish the prudence and ethics boundaries within which all executive activity and decisions must take place.
      4. GOVERNANCE PROCESS: Specification of how the Board conceives, carries out and monitors its own task.
      5. BOARD/MANAGEMENT DELEGATION: How authority is delegated and its proper use monitored: the CEO’s role, authority and accountability.
        1. The Board will assure successful CEO performance on Ends and Management Limitations.
        2. The Board will establish the public policy positions/statements of SCPhA. 
        3. The Board will make determinations regarding the dues for membership in SCPhA. 
        4. The Board shall appoint delegates and alternate delegates to the American Pharmacists Association (at February meeting).
        5. The Board will refer to the House of Delegates:
        6. Recommendations and decision-making regarding changes to the Constitution and Bylaws of SCPhA.
        7. All decisions regarding a proposed expulsion from membership in SCPhA, in accordance with procedures set forth in the Bylaws.
          1. The Board will determine the categories and recipients for SCPhA’s annual awards.

Governance Policies